| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000015786 |
| Receipt No. | R000018371 |
| Official scientific title of the study | The observational study on the safety of dexmedetomidine during endoscopic submucosal dissection for colorectal tumor |
| Date of disclosure of the study information | 2015/07/01 |
| Last modified on | 2016/05/30 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | The observational study on the safety of dexmedetomidine during endoscopic submucosal dissection for colorectal tumor | |
| Title of the study (Brief title) | The observational study on the safety of dexmedetomidine during endoscopic submucosal dissection for colorectal tumor | |
| Region |
|
|
| Condition | ||
| Condition | colorectal tumor | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of the safety of using dexmedetomidine as the intravenous anesthesia in endoscopic submucosal dissection for colorectal tumor |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Patient's circulation and Respiration during ESD for colorectal tumor |
| Key secondary outcomes | Evaluation of drug usage and sedation depth |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who will be performed ESD with colorectal tumor | |||
| Key exclusion criteria | Pregnant patients
Patients with poor general condition Patients with serious cardiovascular or pulmonary disease, renal dysfunction and liver dysfunction. |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Hidemi Goto |
| Organization | Nagoya University Graduate School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 65, Tsuruma-cho, Showa-ku, Nagoya |
| TEL | 052-744-2172 |
| hgoto@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroshi Oshima |
| Organization | Nagoya University Graduate School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 65, Tsuruma-cho, Showa-ku, Nagoya |
| TEL | 052-744-2172 |
| Homepage URL | |
| h-oshima@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Nagoya University Graduate School of Medicine, Department of Gastroenterology and Hepatology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Nagoya University Graduate School of Medicine, Department of Gastroenterology and Hepatology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Evaluation of circulation, Respiration, drug usage and sedation depth, procedural accidents, and so on |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018371 |